Trial Profile
Phase I single-, ascending-dose, pharmacokinetic trial of MF 101 in women with vasomotor symptoms.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 09 Jun 2011
Price :
$35
*
At a glance
- Drugs MF 101 (Primary)
- Indications Menopausal syndrome
- Focus Pharmacokinetics
- Sponsors Bionovo
- 26 Jan 2007 New trial record.